Rhamnolipids exhibit cytotoxicity against leukemic, cervical, breast and bladder cancer cells, disrupt the biofilm formation in dairy, eliminate the oxidative stress by activating antioxidant enzymes (SOD, CAT and GR), and fold the outer membrane protein OmpA. The gene discussed is CAT; the disease is urinary bladder cancer.